“Analysis of Favipiravir Adverse Drug Reactions during COVID-19 Pandemic: A Retrospective Study Based on Iraqi Pharmacovigilance Center Database” (2024) Al Mustansiriyah Journal of Pharmaceutical Sciences, 24(2), pp. 228–236. doi:10.32947/ajps.v24i2.1069.